Genoway SA
PAR:ALGEN

Watchlist Manager
Genoway SA Logo
Genoway SA
PAR:ALGEN
Watchlist
Price: 3.76 EUR 0.27% Market Closed
Market Cap: 33.9m EUR
Have any thoughts about
Genoway SA?
Write Note

Relative Value

The Relative Value of one ALGEN stock under the Base Case scenario is 7.39 EUR. Compared to the current market price of 3.76 EUR, Genoway SA is Undervalued by 49%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALGEN Relative Value
Base Case
7.39 EUR
Undervaluation 49%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
82
vs Industry
82
Median 3Y
2
Median 5Y
1.9
Industry
7.7
Forward
1.3
vs History
26
vs Industry
7
Median 3Y
23.5
Median 5Y
-8.3
Industry
22.7
Forward
35
vs History
49
vs Industry
9
Median 3Y
5.1
Median 5Y
4.7
Industry
21.6
vs History
15
vs Industry
2
Median 3Y
-10.8
Median 5Y
-3.5
Industry
25.2
vs History
85
vs Industry
41
Median 3Y
2.1
Median 5Y
2.1
Industry
2.5
vs History
88
vs Industry
71
Median 3Y
2.1
Median 5Y
2.1
Industry
7.7
Forward
1.3
vs History
88
vs Industry
71
Median 3Y
2.2
Median 5Y
2.2
Industry
9
vs History
96
vs Industry
11
Median 3Y
9.5
Median 5Y
17
Industry
4.2
Forward
10.1
vs History
42
vs Industry
7
Median 3Y
20.2
Median 5Y
-16.3
Industry
4.1
Forward
31.4
vs History
49
vs Industry
9
Median 3Y
5
Median 5Y
4.7
Industry
5.7
vs History
49
vs Industry
2
Median 3Y
7.7
Median 5Y
6.9
Industry
3.6
vs History
71
vs Industry
52
Median 3Y
1.4
Median 5Y
1.4
Industry
4.6

Multiples Across Competitors

ALGEN Competitors Multiples
Genoway SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Genoway SA
PAR:ALGEN
32.5m EUR 1.5 25.9 5.3 18.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
FR
Genoway SA
PAR:ALGEN
Average P/E: 177.9
25.9
-41%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
FR
Genoway SA
PAR:ALGEN
Average EV/EBITDA: 15.5
5.3
-24%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
FR
Genoway SA
PAR:ALGEN
Average EV/EBIT: 22
18.7
-30%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top